February 8, 2017 / 12:46 PM / 6 months ago

BRIEF-Theratechnologies posts Q4 earnings per share C$0.00

Feb 8 (Reuters) - Theratechnologies Inc

* Theratechnologies announces financial results for fiscal year 2016

* Q4 revenue C$10.38 million versus I/B/E/S view c$9.6 million

* Q4 earnings per share C$0.00

* Theratechnologies Inc - anticipate that FY net sales revenue will be in range of $40 million to $42 million

* Theratechnologies -"we are now finalizing our plans for launch of ibalizumab in United States, which we believe will occur in 2017, if approved" Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below